The ROC curve corresponding to each GEO dataset further verified the sensitivity and specificity of WDR62 as a biomarker for the diagnosis of ovarian cancer, with AUC values all greater than 0.9, as shown in Fig. 2B. Additionally, Kaplan-Meier Plotter survival analysis demonstrated that high WDR62 expression was associated with poor survival prognosis of ovarian cancer patients, with elevated levels correlating with shorter the overall survival (OS), progression-free survival (PFS), and post-progression survival (PPS) (Figs. 1G and 2C). Here, WDR62 is linked to ovarian carcinoma.